Multipotent mesenchymal stromal cell therapy and risk of malignancies.
about
Sepsis: From Pathophysiology to Individualized Patient CareSafety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant RecipientsConcise review: therapeutic potential of adipose tissue-derived angiogenic cellsA review on the use of cell therapy in the treatment of tendon disease and injuriesTherapeutic Development of Mesenchymal Stem Cells or Their Extracellular Vesicles to Inhibit Autoimmune-Mediated Inflammatory Processes in Systemic Lupus Erythematosus.Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes.Chromosomal stability of mesenchymal stromal cells during in vitro culture.Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipientsAltered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells.An enzymatic method to rescue mesenchymal stem cells from clotted bone marrow samplesFrom bench to bedside: use of human adipose-derived stem cells.Safety and Potential Effect of a Single Intracavernous Injection of Autologous Adipose-Derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-Label Phase I Clinical Trial.Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials.The advancing field of cell-based therapy: insights and lessons from clinical trials.Adult human mesenchymal stromal cells and the treatment of graft versus host disease.First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.The current landscape of adipose-derived stem cells in clinical applications.Caveats of mesenchymal stem cell therapy in solid organ transplantation.Rationale for the potential use of mesenchymal stromal cells in liver transplantation.The role of stem cell therapies in degenerative lumbar spine disease: a review.Australasian College of Sports Physicians-position statement: the place of mesenchymal stem/stromal cell therapies in sport and exercise medicine.Insurance approval of mesenchymal stem cell for acute GVHD in Japan: need of follow up for some remaining concerns.Mesenchymal Stem Cell-Derived Microvesicles Modulate Lipopolysaccharides-Induced Inflammatory Responses to Microglia Cells.Inflammatory Chemokines MIP-1δ and MIP-3α Are Involved in the Migration of Multipotent Mesenchymal Stromal Cells Induced by Hepatoma Cells.The Safety and Efficacy of Cell-Assisted Fat Grafting to Traditional Fat Grafting in the Anterior Mid-Face: An Indirect Assessment by 3D Imaging.Adoptive cell transfer in autoimmune hepatitis.The Current Status of Stem-Cell Therapy in Erectile Dysfunction: A Review.Characteristics of human adipose mesenchymal stem cells isolated from healthy and cancer affected people and their interactions with human breast cancer cell line MCF-7 in vitro.Accumulation of spontaneous γH2AX foci in long-term cultured mesenchymal stromal cells.Adipose-derived stem cells in orthopaedic pathologies.(Mesenchymal) Stem Cell-Based Therapy in Cisplatin-Induced Acute Kidney Injury Animal Model: Risk of Immunogenicity and Tumorigenicity.Mesenchymal Stromal Cells for AKI after Cardiac Surgery.Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial.Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study
P2860
Q26799911-E36FEFCB-7036-4BE1-A1A9-DC1679B6508FQ26799916-87A43AD4-E011-4202-AC45-F3445DAE3466Q26998587-2607E8E2-09F2-48CA-884C-DAE30F025D34Q28251262-7B72BB2E-C6B8-40C9-886B-C57AAD3E58F1Q33653621-CF253C42-6308-4FA7-ADD7-F28F2BC78EC2Q33722631-3DE45D1B-2D47-4D9B-AD91-3D06C29E09B4Q33917128-EC75B40F-B7F7-4DBC-99E7-AA5C2525A90BQ34753440-C793FEE4-46C6-49A4-924E-7547148FECCFQ35037638-11E59E2B-5CF6-4C8F-8152-F0738DC44D2FQ35970592-F210723E-1E8D-44CF-96BE-DDA806E84AA8Q36257063-00A8E12D-B07B-424A-B5BD-802A73661E29Q36753915-FBBAA426-B9BE-40C7-A19B-681DA5B2EE53Q37079961-84D75D90-A8E2-41F6-9A17-54D03B982F60Q37328786-DAA744A0-F154-44E7-B32C-A6A9FE4DB2DBQ37622055-ECF6A983-BA65-4795-931F-A168B3426CA7Q37686456-BC053884-B3D2-47D1-8599-3289A6E10D4CQ38210142-06C48576-3EB9-4EBB-9F49-67FC35176015Q38235872-4B09D3E0-1361-4358-936B-A9F4BD6FD718Q38282065-B64F4A1B-2E42-4651-B49C-8EC4E4D71D99Q38370139-456818C2-15E8-4A36-803A-32A12B61143BQ38678597-FCC3C587-29C0-4FD3-B597-3F6B53BE5B6CQ38694213-FD148441-8667-4EDF-90A4-B0D66A7C25ADQ38730368-F86CAA06-318D-47B8-95A2-4D279B0166CBQ38921024-DE2D5B00-FE9F-48D7-B599-B60E84461504Q38967828-63C17DF4-AA71-47FC-B143-EBB180BBBEEEQ39035161-FC5D6398-4C82-4709-A33D-8630E8339570Q39067832-951B5F34-CEA2-434D-ACDE-C2B0D04232EAQ39071952-7B02A12C-DEB8-4FC0-910E-080842329AB3Q42017548-AB214188-EFD8-4348-AE92-6418EFF1393AQ47290431-C45B84CB-1185-42C5-8357-06C15F3FFAE8Q47706038-67FC57DE-3BE1-4B4C-839A-F3A91FB5AE1BQ48139400-6EF4514D-2B13-4689-8696-AA0FC8BD4B26Q52668825-91981C3C-812B-4E28-B3C6-EBF40B419041Q59135921-429F7934-A835-4845-92AB-D243B4B8A7A8
P2860
Multipotent mesenchymal stromal cell therapy and risk of malignancies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Multipotent mesenchymal stromal cell therapy and risk of malignancies.
@en
Multipotent mesenchymal stromal cell therapy and risk of malignancies.
@nl
type
label
Multipotent mesenchymal stromal cell therapy and risk of malignancies.
@en
Multipotent mesenchymal stromal cell therapy and risk of malignancies.
@nl
prefLabel
Multipotent mesenchymal stromal cell therapy and risk of malignancies.
@en
Multipotent mesenchymal stromal cell therapy and risk of malignancies.
@nl
P2093
P2860
P1476
Multipotent mesenchymal stromal cell therapy and risk of malignancies.
@en
P2093
Federica Casiraghi
Mauro Abbate
Norberto Perico
P2860
P2888
P356
10.1007/S12015-011-9345-4
P577
2013-02-01T00:00:00Z